Now livetag icon
The official Gen AI Landscape report for 2026 is here. Don’t miss out!Get your copybanner icon
Fujirebio

July 2026

Fujirebio Market Share Analysis for July 2026

fujirebio is an r&d-driven company constantly developing new technologies and unique biomarkers with high clinical value. our group mission is to create new value in healthcare and thereby contribute to human health and the future of medical care.
Year Founded1950
Employees1001 - 5000
Annual Revenue--
fujirebio.com
Fujirebio
Fujirebio (including company regionals)
  • fujirebio.com
    fujirebio.com
See more website traffic and engagement information

Total visits to Fujirebio's top domains

Understand Fujirebio market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

Avg. visit duration in Fujirebio's top domains

Analyze Fujirebio engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

Avg. pageviews on Fujirebio's top domains

See how Fujirebio keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

Want to gain deeper traffic insights?

Filter 20.3M+ online businesses. Discover new leads when their traffic spikes, when they start or stop using technologies, or when they get positive press.



Top technologies used by Fujirebio

These are the website technologies, by industry, used by Fujirebio top domains

Advertising (4)

DoubleClick

DoubleClick

Audio Video Media (3)

HTTP Live Streaming (HLS)

HTTP Live Streaming (HLS)

Email Services (3)

Sendgrid

Sendgrid

Mobile (3)

Meta Viewport

Meta Viewport

More Technologies

9

See all

Ready to discover high quality prospects?

Identify what technologies a website uses to craft the perfect sales pitch, and shorten the sales cycle with the Similarweb Sales Intelligence Solution.


News & Signals from Fujirebio

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAlzinova AB partnered with Fujirebio Group on Jun 24th '26.Alzinova AB (publ) ("Alzinova" or "the Company") today announces that it has entered into a non-binding Letter of Intent ("LoI") with Fujirebio, a global provider of in vitro diagnostic solutions, regarding the potential development and commercialization of a blood-based diagnostic test for Alzheimer's disease based on Alzinova's proprietary Aβ42CC oligomer technology.
NewsFujirebio Group launches lumipulse G NfL Blood assay.Fujirebio announces CE marking of the fully automated lumipulse(r) G NfL Blood assay.
NewsFujirebio Holdings, Inc. attends event AAIC 2025.Fujirebio introduces its Neuro Expert Toolbox (NExT) at AAIC 2025.

See all Fujirebio signals

Focus your sales teams on the most promising opportunities. By prioritizing opportunities and engaging at the right time, you can optimize efforts and close more deals.